Ian Dunn to Protein Kinase Inhibitors
This is a "connection" page, showing publications Ian Dunn has written about Protein Kinase Inhibitors.
Connection Strength
0.243
-
Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review. J Neurooncol. 2025 Oct 30; 176(1):58.
Score: 0.216
-
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst. 2016 Feb; 108(2).
Score: 0.027